Over the previous a number of weeks, audits and inspections have been carried out throughout 49 entities spanning on-line pharmacy warehouses, drug wholesalers, retailers, and wellness and slimming clinics throughout a number of areas of the nation.
Additionally Learn: Rs 450 to Rs 4,200: Drugmakers rush in to win the enterprise of shedding weight
The inspections centered on essential violations, together with unauthorised sale, improper prescription practices, and deceptive promotional actions, with notices subsequently issued to all defaulting entities, the drug regulator mentioned in a press release.
The regulator has mentioned that the surveillance will proceed to be intensified within the coming weeks and non-compliances shall be dealt strictly with actions together with cancellation of licenses, penalties, and prosecution underneath relevant legal guidelines.
The current introduction of a number of generic variants of GLP-1weight loss medication within the Indian market has raised important considerations over their on-demand availability throughout retail pharmacies, on-line platforms, wholesalers, and wellness clinics, given the intense hostile results and well being dangers related to their use with out correct medical supervision.
Taking cognizance of the state of affairs, India’s Medicine Controller, in collaboration with State Regulators, initiated a sequence of focused actions to curb malpractices throughout the pharmaceutical provide chain and stop unauthorized sale and use. As a part of these measures, an advisory was earlier prohibiting producers from partaking in surrogate commercials or any type of oblique promotion that would mislead shoppers or encourage off-label utilization.
Additionally Learn: Natco launches Rs 1,290 semaglutide in India, undercuts diabetes drug costs
“Within the current weeks, enforcement actions have been considerably scaled up,” it additional mentioned.
The drug regulator has suggested individuals to take these drugs “solely underneath the steering of certified medical practitioners”.
“It is very important reiterate right here that the drug has been permitted in India with situation of prescription by Endocrinologists and Inside Drugs Specialist and for some indications by Cardiologists solely”.
